Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Palladia Oral is dosed at 2.75–3.25 mg/kg PO q48h in dogs, per PALLADIA - Toceranib Phosphate Tablet [US Product Label for Dogs]. Zoetis Inc.; 2018. — Plumb's Veterinary Drug Handbook, 10th Ed, p.1278. Palladia Oral is used in dogs for Patnaik grade II or III recurrent cutaneous mast cell tumors, with or without regional lymph node involvement. Routes documented in dogs: PO. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Palladia Oral in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Toceranib Phosphate
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| PO | 2.75–3.25 mg/kg | q48h | Long-term per oncologist | Patnaik grade II or III recurrent cutaneous mast cell tumors, with or without regional lymph node involvement | Strong | PALLADIA - Toceranib Phosphate Tablet [US Product Label for Dogs]. Zoetis Inc.; 2018. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae09ae83-0812-4ddc-92e3-730f7a1ae449 — Plumb's Veterinary Drug Handbook, 10th Ed, p.1278 |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Same as toceranib. Veterinary-labeled multi-target TKI. Every-other-day dosing protocol.
Same as toceranib. This entry represents the specific veterinary product labeling. Handler precautions: gloves required, do not break tablets.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Palladia Oral dose range in dogs, with cited source references: PO 2.75–3.25 mg/kg q48h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Palladia Oral in dogs: PO.
Cited course lengths for Palladia Oral in dogs include: Long-term per oncologist. Duration depends on the indication — match it to the specific dose rule in the table above.
Palladia Oral is indicated in dogs for: Patnaik grade II or III recurrent cutaneous mast cell tumors, with or without regional lymph node involvement.
These are general warnings for Palladia Oral across species; consult the dog dosing table above for species-specific guidance. Same as toceranib. This entry represents the specific veterinary product labeling. Handler precautions: gloves required, do not break tablets.
Why a species-specific page? Palladia Oral pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.